Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 24, 2023 - Issue 3-4
Submit an article Journal homepage
2,342
Views
3
CrossRef citations to date
0
Altmetric
Clinical Measurement

Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R

Christina N. Fournier1 Emory University Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA and;2 Department of Veterans Affairs, Atlanta VA Medical Center, Atlanta, GA, USACorrespondence[email protected]
View further author information
,
Virginia James1 Emory University Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA and;2 Department of Veterans Affairs, Atlanta VA Medical Center, Atlanta, GA, USAView further author information
&
Jonathan D. Glass1 Emory University Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA andView further author information
Pages 311-316 | Received 21 Sep 2022, Accepted 28 Nov 2022, Published online: 07 Dec 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Juan Francisco Vázquez-Costa. (2023) Do we really need to calculate a minimal important difference for ALSFRS-R?: A letter in response to ‘Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R’ published in Vol. 24(3–4), pp. 311–316. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 0:0, pages 1-2.
Read now
Muzammil Arif Din Abdul Jabbar, Ling Guo, Sonakshi Nag, Yang Guo, Zachary Simmons, Erik P. Pioro, Savitha Ramasamy & Crystal Jing Jing Yeo. Predicting amyotrophic lateral sclerosis (ALS) progression with machine learning. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 0:0, pages 1-14.
Read now
Christina N. Fournier & Jonathan D. Glass. The importance of understanding minimal important difference for ALSFRS-R: A reply to ‘Do we really need to calculate a minimal important difference for ALSFRS-R?’ https://doi.org/10.1080/21678421.2023.2248199. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 0:0, pages 1-2.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.